About PD SELF
The self-efficacy program was developed in 2013 by PDF Research Advocate Diane Cook, pictured above.
Photo credit: Chris Jorda Photography
Upcoming CEU Opportunities
- PD ExpertBriefing: Diagnosis PD, Now What? Managing the First Few Years with Parkinson’s (Online - Tuesday, March 7)
- PDF Nurse Webinar Series: Nursing Solutions: PD Medication Adherence Challenges (Online - Tuesday, March 28)
- Occupational Therapy: Across the Parkinson’s Disease Continuum (Online - Available Now)
Background & Goals
What happens when a person is diagnosed with Parkinson’s?
Many people are handed a diagnosis with very little guidance on what to do next. But the diagnosis is life changing. Facing life with a chronic progressive disease means facing changes to health, relationships, family life, employment and finances.
Research tells us that when people are given the resources to cope with these changes, they are empowered to take an active role in managing PD, leading to better health and quality of life.
PD SELF (Self-Efficacy Learning Forum) is an innovative disease management program that offers this approach. It was developed in 2013 by Diane Cook as part of a clinical trial sponsored by the Colorado Neurological Institute.
Based on the psychosocial theory of self-efficacy, PD SELF helps people newly diagnosed with PD to create a personalized approach to managing their disease. Self-efficacy is the confidence a person has in his or her ability to influence an outcome or be successful in achieving a result. Self-efficacy beliefs determine how people think, feel and motivate themselves. It is increasingly used in health care for its effectiveness in helping people to adopt healthier behaviors.
A central focus of PD SELF is to help people strengthen self-efficacy beliefs, thereby positively influencing the management of their disease. At the end of the first clinical trial testing this approach, researchers found that PD SELF:
- Improved mental health and well-being of people with PD and their care partners.
- Decreased participants’ stress, anxiety and depression and improved sleep.
- Improved participants’ emotional well-being, even when PD (or general health) declined.
- Led to long-term improvement in the areas above, with changes observed for as long as one year after the clinical trial ended.
- Led participants to become more active in the Parkinson’s community, for example through increased enrollment in clinical trials.
Given its positive results, PDF is seeking teams of community leaders to help us share the benefits of this program throughout the Parkinson’s disease community.